CD14 and hematoma: One study investigating the acute inflammatory response to ICH found that circulating neutrophils and CD14 + monocytes/macrophages in a hematoma progress through two distinct stages: the first days after hemorrhage display a glycolytic and pro-inflammatory profile, while past day 4, anti-inflammatory and anti-oxidative pathways are upregulated [23].